Anemia 0 6 0 6 B-chronic_disease
( 7 8 7 8 O
Hgb<9 8 13 8 13 B-clinical_variable
) 13 14 13 14 O
and 15 18 15 18 O
Severe 19 25 19 25 B-chronic_disease
Renal 26 31 26 31 I-chronic_disease
Insufficiency 32 45 32 45 I-chronic_disease
( 46 47 46 47 O
individuals 47 58 47 58 O
with 59 63 59 63 O
creatinine 64 74 64 74 B-clinical_variable
clearance 75 84 75 84 I-clinical_variable
< 85 86 85 86 O
30 86 88 86 88 B-upper_bound
by 89 91 89 91 O
the 92 95 92 95 O
Cockcroft 96 105 96 105 O
- 105 106 105 106 O
Gault 106 111 106 111 O
formula 112 119 112 119 O
) 119 120 119 120 O

Diabetes 0 8 121 129 B-chronic_disease
( 9 10 130 131 O
if 10 12 131 133 O
on 13 15 134 136 O
insulin 16 23 137 144 B-treatment
therapy 24 31 145 152 I-treatment
) 31 32 152 153 O

Due 0 3 154 157 O
to 4 6 158 160 O
the 7 10 161 164 O
typical 11 18 165 172 O
age 19 22 173 176 O
of 23 25 177 179 O
patients 26 34 180 188 O
with 35 39 189 193 O
HF 40 42 194 196 O
, 42 43 196 197 O
all 44 47 198 201 O
women 48 53 202 207 B-gender
will 54 58 208 212 O
be 59 61 213 215 O
postmenopausal 62 76 216 230 O
( 77 78 231 232 O
either 78 84 232 238 O
natural 85 92 239 246 O
or 93 95 247 249 O
surgical 96 104 250 258 O
) 104 105 258 259 O
defined 106 113 260 267 O
as 114 116 268 270 O
a 117 118 271 272 O
cessation 119 128 273 282 O
of 129 131 283 285 O
menses 132 138 286 292 O
for 139 142 293 296 O
at 143 145 297 299 O
least 146 151 300 305 O
2 152 153 306 307 B-lower_bound
years 154 159 308 313 I-lower_bound
, 159 160 313 314 O
and 161 164 315 318 O
in 165 167 319 321 O
women 168 173 322 327 O
without 174 181 328 335 O
a 182 183 336 337 O
uterus 184 190 338 344 O
, 190 191 344 345 O
follicle 192 200 346 354 B-clinical_variable
stimulating 201 212 355 366 I-clinical_variable
hormone 213 220 367 374 I-clinical_variable
( 221 222 375 376 I-clinical_variable
FSH 222 225 376 379 I-clinical_variable
) 225 226 379 380 I-clinical_variable
> 227 228 381 382 O
40 228 230 382 384 B-lower_bound
IU 231 233 385 387 I-lower_bound
/ 233 234 387 388 I-lower_bound
L 234 235 388 389 I-lower_bound

End 0 3 390 393 B-cancer
- 3 4 393 394 I-cancer
stage 4 9 394 399 I-cancer
Malignancy 10 20 400 410 I-cancer

Optimal 0 7 411 418 B-treatment
therapy 8 15 419 426 I-treatment
will 16 20 427 431 O
be 21 23 432 434 O
according 24 33 435 444 O
to 34 36 445 447 O
American 37 45 448 456 O
Heart 46 51 457 462 O
Association 52 63 463 474 O
( 64 65 475 476 O
AHA 65 68 476 479 O
) 68 69 479 480 O
/American 70 79 481 490 O
College 80 87 491 498 O
of 88 90 499 501 O
Cardiology 91 101 502 512 O
( 102 103 513 514 O
ACC 103 106 514 517 O
) 106 107 517 518 O
and 108 111 519 522 O
Heart 112 117 523 528 O
Failure 118 125 529 536 O
Society 126 133 537 544 O
of 134 136 545 547 O
America 137 144 548 555 O
( 145 146 556 557 O
HFSA 146 150 557 561 O
) 150 151 561 562 O
HF 152 154 563 565 O
guidelines 155 165 566 576 O
, 165 166 576 577 O
including 167 176 578 587 O
treatment 177 186 588 597 O
with 187 191 598 602 O
angiotensin 192 203 603 614 B-treatment
- 203 204 614 615 I-treatment
converting 204 214 615 625 I-treatment
enzyme 215 221 626 632 I-treatment
( 222 223 633 634 I-treatment
ACE 223 226 634 637 I-treatment
) 226 227 637 638 I-treatment
and 228 231 639 642 O
-blocker 232 240 643 651 O
therapy 241 248 652 659 I-treatment
( 249 250 660 661 O
for 250 253 661 664 O
at 254 256 665 667 O
least 257 262 668 673 O
6 263 264 674 675 B-lower_bound
weeks 265 270 676 681 I-lower_bound
) 270 271 681 682 O
, 271 272 682 683 O
or 273 275 684 686 O
have 276 280 687 691 O
documented 281 291 692 702 O
reason 292 298 703 709 O
for 299 302 710 713 O
variation 303 312 714 723 O
, 312 313 723 724 O
including 314 323 725 734 O
medication 324 334 735 745 O
intolerance 335 346 746 757 O
, 346 347 757 758 O
contraindication 348 364 759 775 O
, 364 365 775 776 O
patient 366 373 777 784 O
preference 374 384 785 795 O
, 384 385 795 796 O
or 386 388 797 799 O
personal 389 397 800 808 O
physician 398 407 809 818 O
's 407 409 818 820 O
judgment 410 418 821 829 O

Patient 0 7 830 837 O
enrollment 8 18 838 848 O
will 19 23 849 853 O
be 24 26 854 856 O
limited 27 34 857 864 O
to 35 37 865 867 O
those 38 43 868 873 O
individuals 44 55 874 885 O
with 56 60 886 890 O
New 61 64 891 894 B-clinical_variable
York 65 69 895 899 I-clinical_variable
Heart 70 75 900 905 I-clinical_variable
Association 76 87 906 917 I-clinical_variable
( 88 89 918 919 I-clinical_variable
NYHA 89 93 919 923 I-clinical_variable
) 93 94 923 924 I-clinical_variable
class 95 100 925 930 B-lower_bound
II 101 103 931 933 I-lower_bound
and 104 107 934 937 O
III 108 111 938 941 B-upper_bound
symptoms 112 120 942 950 O
, 120 121 950 951 O
left 122 126 952 956 B-clinical_variable
ventricular 127 138 957 968 I-clinical_variable
ejection 139 147 969 977 I-clinical_variable
fraction 148 156 978 986 I-clinical_variable
< 157 158 987 988 O
35 158 160 988 990 B-upper_bound
% 160 161 990 991 I-upper_bound
( 162 163 992 993 B-clinical_variable
LVEF 163 167 993 997 I-clinical_variable
) 167 168 997 998 I-clinical_variable
, 168 169 998 999 O
with 170 174 1000 1004 O
no 175 177 1005 1007 O
or 178 180 1008 1010 O
minimal 181 188 1011 1018 O
smoking 189 196 1019 1026 O
history 197 204 1027 1034 O
( 205 206 1035 1036 O
< 206 207 1036 1037 O
15 207 209 1037 1039 B-upper_bound
pk 210 212 1040 1042 I-upper_bound
yrs 213 216 1043 1046 I-upper_bound
) 216 217 1046 1047 O
, 217 218 1047 1048 O
and 219 222 1049 1052 O
without 223 230 1053 1060 O
pacemakers 231 241 1061 1071 O

Patients 0 8 1072 1080 O
will 9 13 1081 1085 O
be 14 16 1086 1088 O
sedentary 17 26 1089 1098 O
, 26 27 1098 1099 O
defined 28 35 1100 1107 O
here 36 40 1108 1112 O
as 41 43 1113 1115 O
no 44 46 1116 1118 O
regular 47 54 1119 1126 O
physical 55 63 1127 1135 O
activity 64 72 1136 1144 O
for 73 76 1145 1148 O
at 77 79 1149 1151 O
least 80 85 1152 1157 O
the 86 89 1158 1161 O
prior 90 95 1162 1167 B-upper_bound
6 96 97 1168 1169 I-upper_bound
months 98 104 1170 1176 I-upper_bound
and 105 108 1177 1180 O
current 109 116 1181 1188 O
activity 117 125 1189 1197 O
level 126 131 1198 1203 O
will 132 136 1204 1208 O
be 137 139 1209 1211 O
documented 140 150 1212 1222 O
by 151 153 1223 1225 O
an 154 156 1226 1228 O
activity 157 165 1229 1237 O
questionnaire 166 179 1238 1251 O

Patients 0 8 1252 1260 O
with 9 13 1261 1265 O
HF 14 16 1266 1268 B-chronic_disease
secondary 17 26 1269 1278 O
to 27 29 1279 1281 O
significant 30 41 1282 1293 O
uncorrected 42 53 1294 1305 O
primary 54 61 1306 1313 B-chronic_disease
valvular 62 70 1314 1322 I-chronic_disease
disease 71 78 1323 1330 I-chronic_disease

Peripheral 0 10 1331 1341 B-chronic_disease
Vascular 11 19 1342 1350 I-chronic_disease
Disease 20 27 1351 1358 I-chronic_disease

Severe 0 6 1359 1365 B-chronic_disease
Valvular 7 15 1366 1374 I-chronic_disease
Heart 16 21 1375 1380 I-chronic_disease
Disease 22 29 1381 1388 I-chronic_disease

Severe 0 6 1389 1395 B-chronic_disease
chronic 7 14 1396 1403 I-chronic_disease
obstructive 15 26 1404 1415 I-chronic_disease
pulmonary 27 36 1416 1425 I-chronic_disease
disease 37 44 1426 1433 I-chronic_disease
( 45 46 1434 1435 I-chronic_disease
COPD 46 50 1435 1439 I-chronic_disease
) 50 51 1439 1440 I-chronic_disease

Sleep 0 5 1441 1446 B-chronic_disease
- 5 6 1446 1447 I-chronic_disease
related 6 13 1447 1454 I-chronic_disease
Breathing 14 23 1455 1464 I-chronic_disease
Disorder 24 32 1465 1473 I-chronic_disease

These 0 5 1474 1479 O
include 6 13 1480 1487 O
a 14 15 1488 1489 O
diagnosis 16 25 1490 1499 O
of 26 28 1500 1502 O
Dementia 29 37 1503 1511 B-chronic_disease

Women 0 5 1512 1517 B-gender
currently 6 15 1518 1527 O
taking 16 22 1528 1534 O
hormone 23 30 1535 1542 B-treatment
replacement 31 42 1543 1554 I-treatment
therapy 43 50 1555 1562 I-treatment
( 51 52 1563 1564 I-treatment
HRT 52 55 1564 1567 I-treatment
) 55 56 1567 1568 I-treatment

mitral 0 6 1569 1575 B-chronic_disease
regurgitation 7 20 1576 1589 I-chronic_disease
secondary 21 30 1590 1599 O
to 31 33 1600 1602 O
left 34 38 1603 1607 B-chronic_disease
ventricular 39 50 1608 1619 I-chronic_disease
dysfunction 51 62 1620 1631 I-chronic_disease

patients 0 8 1632 1640 O
with 9 13 1641 1645 O
uncontrolled 14 26 1646 1658 O
Hypertension 27 39 1659 1671 B-clinical_variable
( 40 41 1672 1673 O
> 41 42 1673 1674 O
160/100 42 49 1674 1681 B-lower_bound
) 49 50 1681 1682 O

subjects 0 8 1683 1691 O
with 9 13 1692 1696 O
a 14 15 1697 1698 O
history 16 23 1699 1706 O
of 24 26 1707 1709 O
stable 27 33 1710 1716 O
cardiomyopathy 34 48 1717 1731 B-chronic_disease
( 49 50 1732 1733 O
ischemic 50 58 1733 1741 B-chronic_disease
and 59 62 1742 1745 O
non 63 66 1746 1749 B-chronic_disease
- 66 67 1749 1750 I-chronic_disease
ischemic 67 75 1750 1758 I-chronic_disease
, 75 76 1758 1759 O
> 77 78 1760 1761 O
3 78 79 1761 1762 B-lower_bound
months 80 86 1763 1769 I-lower_bound
duration 87 95 1770 1778 O
, 95 96 1778 1779 O
ages 97 101 1780 1784 B-age
45 102 104 1785 1787 B-lower_bound
- 104 105 1787 1788 O
75 105 107 1788 1790 B-upper_bound
yrs 108 111 1791 1794 I-upper_bound
) 111 112 1794 1795 O
despite 113 120 1796 1803 O
a 121 122 1804 1805 O
minimum 123 130 1806 1813 O
of 131 133 1814 1816 O
6 134 135 1817 1818 B-lower_bound
weeks 136 141 1819 1824 I-lower_bound
of 142 144 1825 1827 O
optimal 145 152 1828 1835 B-treatment
treatment 153 162 1836 1845 I-treatment

